Toggle Sidebar
Tracking
The Digest
Dashboard
Changes
Readouts
Trials
Companies
Comparisons
Automation
Nightly sweep
Settings
Tracker
↳
Sign in
Sign in
Explore the registry
Track Sar441344's trials
Proof-of-concept Study for SAR441344 (Frexalimab) in Relapsing Multiple Sclerosis
SAR441344 IV
Ongoing
Active not recruiting
Phase 2
Open NCT04879628 on ClinicalTrials.gov ↗
Population
Loading…
Intervention
Loading…
Comparator
Loading…
Outcomes
Loading…
Overview
Endpoints
Eligibility
Full record
NCT04879628 · Trial Tracker · ComplyRx
